Penney Plans Bangladesh Audits

Related Link: 

J.C. Penney plans to beef up its audits of factories in Bangladesh by requiring them for the first time to undergo structural and engineering inspections.

Recycling Project: Green Burials

Related Link: 

The dearly departed can rest at sea in a reef ball, or in space for $25,000. Now, even burials are becoming environmentally friendly.

E.ON to Build Power Units for Metro

Related Link: 

E.ON has made its first significant move in Germany's decentralized power market by agreeing to build four combined heat and power units for retailer Metro.

ENRC Seeks Revised Offer From Consortium

Related Link: 

Eurasian Natural Resources rejected a takeover offer from a consortium of buyers that it said undervalues the business, and the U.K.-listed, Kazakhstan-focused miner has asked the consortium to make a revised offer.

Nice Boat, No Dock

Related Link: 

Superyachts are all the rage. But the most coveted marinas in the Mediterranean, the Caribbean and Asia are telling owners there's no room to park.

Continental Resources CEO Harold Hamm

Related Link: 

How chairman and CEO of Continental Resources, Harold Hamm, went from a farm boy to an oil tycoon.

Currency Traders Follow the Leader

Related Link: 

Copycat programs such as Currensee and eToro are opening the doors to currency investors too fearful to make their own trades.

For Sale: Eastern Europe

Related Link: 

Few wealth managers would have considered Eastern Europe a legitimate investment opportunity. Now, an entire region is trying to unload everything from national railroads to postal services.

Abe Seeks to Get Japan Inc. to Spend

Related Link: 

The prime minister pledged action to encourage businesses to increase their spending as he seeks to turn recent improvements in the economy into sustainable growth.

India Widens Drug-Price Controls

Related Link: 

India has significantly widened its control over drug prices, a decision that will make medicines more affordable for people but hurt the profit margins of pharmaceutical companies.

Syndicate content